- Home
- SNCY vs CERT Comparison
SNCY vs CERT Comparison
Compare SNCY & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SNCY | CERT |
|---|---|---|
| Founded | 1982 | 2008 |
| Country | United States | United States |
| Employees | N/A | 1576 |
| Industry | Air Freight/Delivery Services | Retail: Computer Software & Peripheral Equipment |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 978.7M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SNCY | CERT |
|---|---|---|
| Price | $16.84 | $6.39 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 10 |
| Target Price | ★ $19.29 | $12.22 |
| AVG Volume (30 Days) | 803.0K | ★ 3.5M |
| Earning Date | 04-30-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | ★ 0.96 | N/A |
| Revenue | ★ $1,126,769,000.00 | $418,838,000.00 |
| Revenue This Year | $9.52 | $4.26 |
| Revenue Next Year | $9.40 | $5.40 |
| P/E Ratio | $16.56 | ★ N/A |
| Revenue Growth | 4.74 | ★ 8.75 |
| 52 Week Low | $8.10 | $6.04 |
| 52 Week High | $22.29 | $15.38 |
Technical Indicators
Market Signals| Indicator | SNCY | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 45.83 | 37.09 |
| Support Level | $10.77 | $6.04 |
| Resistance Level | $18.28 | $7.52 |
| Average True Range (ATR) | 0.74 | 0.32 |
| MACD | -0.07 | 0.00 |
| Stochastic Oscillator | 38.60 | 24.33 |
Price Performance
Historical ComparisonAbout SNCY Sun Country Airlines Holdings Inc.
Sun Country Airlines Holdings Inc operates low-cost air carriers. The business has two operating segments: Passenger and Cargo. The passenger segment has two internal passenger groups Scheduled service and Charter. The Cargo segment provides air cargo services. The majority of the revenue is from the passenger segment.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.